Notification

No new Notification messages

Pre-Apply for Manba Finance IPO
Don't miss out on the latest IPOs! Use Bajaj Broking's Pre-Apply feature.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
astal laboratories limited stock

ASTAL LABORATORIES LIMITED Share Price

112.2 -2.25 (-1.96%)
Sep 19 2024 12:15 PM Pharmaceuticals NSE: ASTALLTD

ASTAL LABORATORIES LIMITED Share Price Update

As of the latest trading session, ASTAL LABORATORIES LIMITED share price is currently at 112.2, which is down by -2.25 from its previous closing. Today, the stock has fluctuated between 112.20 and 112.20. Over the past year, ASTAL LABORATORIES LIMITED has achieved a return of 257.09 %. In the last month alone, the return has been 19.00 %. Read More...

ASTAL LABORATORIES LIMITED Performance

Day Range

Low112.20 High112.20
112.20

52 Week Range

Low 32.05 High 131.70
112.20

ASTAL LABORATORIES LIMITED Share Price

512600

ASTALLTD

img img img img
No Data Available

Open Price

112.20

Prev. Close

114.45

Volume (Shares)

4147.00

Total traded value

4.65

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

ASTAL LABORATORIES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 110.30
PE Ratio (TTM) 40.73
Book Value / Share 23.72
Beta -0.11
ROE 5.47%
EPS (TTM) 2.81
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.69

ASTAL LABORATORIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 13.15
Operating Expense 10.84
Net Profit 1.69
Net Profit Margin (%) 12.85
Earnings Per Share (EPS) 1.72
EBITDA 2.40
Effective Tax Rate (%) 27.77
Particulars MAR 2024 (Values in Cr)
Revenue 12.25
Operating Expense 11.69
Net Profit 0.56
Net Profit Margin (%) 4.57
Earnings Per Share (EPS) 1.11
EBITDA 0.58
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 8.41
Operating Expense 7.93
Net Profit 0.49
Net Profit Margin (%) 5.82
Earnings Per Share (EPS) 1.02
EBITDA 0.50
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 1.62
Operating Expense 1.60
Net Profit 0.03
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 0.07
EBITDA 0.03
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 1.36
Operating Expense 1.36
Net Profit 0.01
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.03
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 23.65
Operating Expense 22.57
Net Profit 0.78
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 1.55
EBITDA 1.13
Effective Tax Rate (%) 27.52
Particulars MAR 2023 (Values in Cr)
Revenue 3.43
Operating Expense 3.57
Net Profit 0.02
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 0.04
EBITDA 0.04
Effective Tax Rate (%) 66.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.23
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.20
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.23
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.07
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.71
ROE % 5.47
ROCE % 7.56
Total Debt to Total Equity 0.01
EBITDA Margin 4.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.98
ROE % 0.39
ROCE % 0.77
Total Debt to Total Equity 0.00
EBITDA Margin 1.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.93
ROE % -0.39
ROCE % -0.19
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.97
ROE % 0.19
ROCE % 0.19
Total Debt to Total Equity 0.00
EBITDA Margin 10.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 12.96
ROE % -0.58
ROCE % -0.58
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.07
Total Assets 36.61
Total Liabilities 36.61
Total Equity 23.33
Share Outstanding 9830100
Price to Book Ratio 1.72
Return on Assets (%) 2.14
Return on Capital (%) 3.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 9.90
Total Liabilities 9.90
Total Equity 5.17
Share Outstanding 3974070
Price to Book Ratio 2.28
Return on Assets (%) 0.16
Return on Capital (%) 0.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.22
Total Liabilities 5.22
Total Equity 5.16
Share Outstanding 3974070
Price to Book Ratio 1.25
Return on Assets (%) -0.32
Return on Capital (%) -0.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 5.30
Total Liabilities 5.30
Total Equity 5.17
Share Outstanding 3974070
Price to Book Ratio 0.67
Return on Assets (%) 0.11
Return on Capital (%) 0.12
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.27
Total Liabilities 5.27
Total Equity 5.17
Share Outstanding 3974070
Price to Book Ratio 0.00
Return on Assets (%) -0.53
Return on Capital (%) -0.54
Particulars MAR 2024 (Values in Cr)
Net Income 1.08
Cash from Operations -5.56
Cash from Investing -6.10
Cash from Financing 17.69
Net change in Cash 5.99
Free Cash Flow 0.35
Particulars MAR 2023 (Values in Cr)
Net Income 0.03
Cash from Operations -1.42
Cash from Investing 1.50
Cash from Financing 0.00
Net change in Cash 0.06
Free Cash Flow -1.42
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations -0.24
Cash from Investing 0.23
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.24
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations -0.18
Cash from Investing 0.20
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow -0.18
Particulars MAR 2020 (Values in Cr)
Net Income -0.02
Cash from Operations -0.19
Cash from Investing 0.20
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.19
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 62.47 40.56 3.49 478.73 34.03 / 77.70
BLISS GVS PHARMA LTD 127.90 13.16 1.39 1344.80 77.65 / 148.95
CIPLA LTD 1651.90 30.01 4.99 133401.99 1132.00 / 1682.75
FERMENTA BIOTECH LIMITED 297.15 0.00 3.02 874.54 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2795.20 61.47 26.63 47352.37 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 62.47 94.65 11.88 478.73 34.03 / 77.70
AMRUTAJAN HEALTH LTD 805.95 54.71 8.07 2330.05 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6703.00 127.92 23.53 16757.50 4050.15 / 7550.00
BLISS GVS PHARMA LTD 127.90 13.77 1.36 1344.80 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 118.60
  • 26 Days 113.70
  • 10 Days 120.80
  • 50 Days 101.80
  • 12 Days 120.50
  • 100 Days 77.90
  • 20 Days 117.00
  • 200 Days 26.40
115.03
PIVOT
First Resistance 115.62
Second Resistance 116.78
Third Resistance 117.37
First Support 113.87
Second Support 113.28
Third Support 112.12
RSI 52.88
MACD 6.79
Commodity Channel Index (CCI) -23.94
ADX 76.99
Williams % R -100.00

Over 1 Month

down

19.00

Over 3 Months

down

153.99

Over 6 Months

down

179.96

Over 1 Year

down

257.09

Over 3 Years

down

116.10

Over 5 Years

down

65.59

ASTAL LABORATORIES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ASTAL LABORATORIES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
80.06
Promoter Holdings
19.93
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Aceso Research Labs Llp Shareholding of Promoter and Promoter Group 1959284.0 19.93
Radha Krishna Doradla Public Shareholding 350000.0 3.56
Satyavani Meduri Public Shareholding 350000.0 3.56
Lekhya Entertainment Pvt Ltd Public Shareholding 300000.0 3.05
Venkata Padmavathi Yechuri Public Shareholding 250000.0 2.54
Kamalakara Rao Yechuri Public Shareholding 250000.0 2.54
Ramamurty Venkata Bhaskara Yadavalli Public Shareholding 150000.0 1.53
Pavani Vupparapalli Public Shareholding 150000.0 1.53
Vupparapalli Chandrasekhar Reddy Public Shareholding 150000.0 1.53
Sana Rambabu . Public Shareholding 150000.0 1.53
Gandharva Financial Services Private Limited Public Shareholding 145000.0 1.48
Siva Nageswara Rao Doradla Public Shareholding 140000.0 1.42
Bosco Armando Menezes Public Shareholding 131767.0 1.34
Emily Bosco Menezes Public Shareholding 120000.0 1.22
R Lakshmi Shobha Public Shareholding 120000.0 1.22
Narayana Marthi Venkata Lakshmi Public Shareholding 110000.0 1.12
Lenus Finvest Private Limited Public Shareholding 100000.0 1.02
Ashok Dama Public Shareholding 100000.0 1.02
Badarinarayana Venkata Meda Public Shareholding 100000.0 1.02
Gayathri Radhakrishnan Public Shareholding 100000.0 1.02
Hari Kishan Bhonagiri Public Shareholding 100000.0 1.02
Jnv Suresh Kumar Public Shareholding 100000.0 1.02
Kotha Vamsi Prasad Public Shareholding 100000.0 1.02
Mallikarjun Gada Public Shareholding 100000.0 1.02
Ramaswamy Anand . Public Shareholding 100000.0 1.02
Sannareddy Suresh Babu Public Shareholding 100000.0 1.02
Goondla Jyothi Public Shareholding 100000.0 1.02

ASTAL LABORATORIES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ASTAL LABORATORIES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ASTAL LABORATORIES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Astal Laboratories Ltd?

Answer Field

The share price of Astal Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 112.20.

What is the Market Cap of Astal Laboratories Ltd?

Answer Field

The market cap of Astal Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,10.30 Cr. as of now.

What is the 52 Week High and Low of Astal Laboratories Ltd?

Answer Field

The 52 Week High and Low of Astal Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 131.70 and ₹ 32.05.

How to Buy Astal Laboratories Ltd share?

Answer Field

You can trade in Astal Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Astal Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 257.09%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader